Research & development

Infant Bacterial Therapeutics' most advanced clinical program is the IBP-9414 project developing a preventive treatment against necrotizing enterocolitis (NEC) and improvement of so-called feeding tolerance in premature infants.
Read more

Calendar

NOVEMBER 25-26, 2019
Nordea Innovation Seminar, Stockholm
Read More